Citations (95)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Krzysztof Łukawski & Stanisław J. Czuczwar. (2021) Understanding mechanisms of drug resistance in epilepsy and strategies for overcoming it. Expert Opinion on Drug Metabolism & Toxicology 17:9, pages 1075-1090.
Read now
Read now
Eleonora Tulli, Giuseppe Di Cara, Giulia Iapadre, Pasquale Striano & Alberto Verrotti. (2021) An update on brivaracetam for the treatment of pediatric partial epilepsy. Expert Opinion on Pharmacotherapy 22:11, pages 1387-1395.
Read now
Read now
Krzysztof Łukawski, Paweł Gryta, Jarogniew Łuszczki & Stanisław J. Czuczwar. (2016) Exploring the latest avenues for antiepileptic drug discovery and development. Expert Opinion on Drug Discovery 11:4, pages 369-382.
Read now
Read now
Petra Malátková & Vladimír Wsól. (2014) Carbonyl reduction pathways in drug metabolism. Drug Metabolism Reviews 46:1, pages 96-123.
Read now
Read now
Barbara Miziak, Magdalena Chrościńska-Krawczyk, Barbara Błaszczyk, Iwona Radzik & Stanisław J Czuczwar. (2013) Novel approaches to anticonvulsant drug discovery. Expert Opinion on Drug Discovery 8:11, pages 1415-1427.
Read now
Read now
G. L. Krauss, H. B. Edwards & B. Lin. (2012) Lacosamide for the treatment of epilepsy. Annals of Medicine 44:7, pages 674-679.
Read now
Read now
Marco Mula. (2012) Recent and future antiepileptic drugs and their impact on cognition: what can we expect?. Expert Review of Neurotherapeutics 12:6, pages 667-671.
Read now
Read now
Pasquale Striano & Salvatore Striano. (2009) New and investigational antiepileptic drugs. Expert Opinion on Investigational Drugs 18:12, pages 1875-1884.
Read now
Read now
Articles from other publishers (87)
Mariana Matias, Adriana O. Santos, Samuel Silvestre & Gilberto Alves. (2023) Fighting Epilepsy with Nanomedicines—Is This the Right Weapon?. Pharmaceutics 15:2, pages 306.
Crossref
Crossref
MARK P. GRILLO. 2022. Drug Metabolism Handbook. Drug Metabolism Handbook
677
702
.
Leonardo Zumerkorn Pipek, Henrique Zumerkorn Pipek & Luiz Henrique Martins Castro. (2022) Seizure control in mono- and combination therapy in a cohort of patients with Idiopathic Generalized Epilepsy. Scientific Reports 12:1.
Crossref
Crossref
Rohit Pal, Karanvir Singh, Shah Alam Khan, Pooja Chawla, Bhupinder Kumar & Md Jawaid Akhtar. (2021) Reactive metabolites of the anticonvulsant drugs and approaches to minimize the adverse drug reaction. European Journal of Medicinal Chemistry 226, pages 113890.
Crossref
Crossref
Giulia Spoto, Maria Concetta Saia, Greta Amore, Eloisa Gitto, Giuseppe Loddo, Greta Mainieri, Antonio Gennaro Nicotera & Gabriella Di Rosa. (2021) Neonatal Seizures: An Overview of Genetic Causes and Treatment Options. Brain Sciences 11:10, pages 1295.
Crossref
Crossref
I. Tejedor, H. Assier, C. Morice, O. Bauvin, P. Carvalho, V. Hébert, C. Gautier, C. Hervouet, P. Joly & F. Tétart. (2021) DRESS with eslicarbazepine: The value of allergological exploration. Annales de Dermatologie et de Vénéréologie 148:3, pages 187-190.
Crossref
Crossref
Alberto Verrotti, Eleonora A. Grasso, Marta Cacciatore, Sara Matricardi & Pasquale Striano. (2020) Potential role of brivaracetam in pediatric epilepsy. Acta Neurologica Scandinavica 143:1, pages 19-26.
Crossref
Crossref
Ameen A. Abu‐Hashem, Usama Fathy & Moustafa A. Gouda. (2020)
Synthesis of 1,2,
4‐triazolopyridazines
, isoxazolofuropyridazines, and tetrazolopyridazines as antimicrobial agents
. Journal of Heterocyclic Chemistry 57:9, pages 3461-3474.
Crossref
Crossref
V. V. Arkhipov, E. A. Sokova, G. I. Gorodetskaya, O. A. Demidova & T. V. Aleksandrova. (2019) New Anticonvulsants: Interchangeability Issues and the Use of Generic Anticonvulsants in Clinical Practice. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 9:2, pages 101-107.
Crossref
Crossref
Wei Chen, Huiyun Huang, Chuanxin Yang, Xiaoqing Hu, Fang Bao & Hui Jiang. (2019) Preoperative Low-dose and High-dose Pregabalin and Cardiovascular Response to Endotracheal Intubation: A Prospective, Randomized, Single-blind, Controlled Study in China. Clinical Therapeutics 41:1, pages 68-77.
Crossref
Crossref
Mohammad Asif, Anita Singh, Shah Alam Khan & Asif Husain. (2018) Studies on new substituted pyridazinones: synthesis and biological evaluation. Brazilian Journal of Pharmaceutical Sciences 54:3.
Crossref
Crossref
Nicholas A. Meanwell. (2018) Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design. Journal of Medicinal Chemistry 61:14, pages 5822-5880.
Crossref
Crossref
Mohammad Asif. (2018) Study of antiepileptic drug fosphenytoin; a prodrug of phenytoin prodrug fosphenytoin. MOJ Drug Design Development & Therapy 2:2.
Crossref
Crossref
Hussein O. Ammar, Mahmoud M. Ghorab, Azza A. Mahmoud & Iman M. Higazy. (2018) Lamotrigine loaded poly-ɛ-(d,l-lactide-co-caprolactone) nanoparticles as brain delivery system. European Journal of Pharmaceutical Sciences 115, pages 77-87.
Crossref
Crossref
Pasquale StrianoVincenzo BelcastroAntonietta CoppolaCarlo MinettiSalvatore Striano. (2016) Antiepileptic Drugs Under Investigation for Treatment of Focal Epilepsy. Clinical Neuropharmacology 39:6, pages 281-287.
Crossref
Crossref
Violina Angelova, Valentin Karabeliov, Pavlina A. Andreeva-Gateva & Jana Tchekalarova. (2016) Recent Developments of Hydrazide/Hydrazone Derivatives and Their Analogs as Anticonvulsant Agents in Animal Models. Drug Development Research 77:7, pages 379-392.
Crossref
Crossref
Mohammad Asif & Anita Singh. (2016) Anticonvulsant Activities of 4-benzylidene-6-(4-methyl-phenyl)-4,5-dihydropyridazin-(2H)-ones and 4-benzylidene-6-(4-chloro-phenyl)-4,5-dihydropyridazin-(2H)-ones. Open Pharmaceutical Sciences Journal 3:1, pages 203-214.
Crossref
Crossref
Hafiz Mawasi, David Bibi & Meir Bialer. (2016) Design and comparative anticonvulsant activity assessment of CNS-active alkyl-carbamoyl imidazole derivatives. Bioorganic & Medicinal Chemistry 24:18, pages 4246-4253.
Crossref
Crossref
Yousong Nie, Min Zhong, Zhiyuan Jiang, Jian Sun, Yangguang Gao, Fei Ding, Hang Li, Yongmin Zhang & Xianran He. (2016) Synthesis and potential anticonvulsant activity of new aryl sulfonyl semicarbazide derivatives. Medicinal Chemistry Research 25:7, pages 1425-1432.
Crossref
Crossref
KennedyKwami Edem Kukuia, ElvisOfori Ameyaw, Eric Woode, PriscillaKolibea Mante & DonatusWewura Adongo. (2016) Enhancement of inhibitory neurotransmission and inhibition of excitatory mechanisms underlie the anticonvulsant effects of Mallotus oppositifolius. Journal of Pharmacy And Bioallied Sciences 8:3, pages 253.
Crossref
Crossref
Yousong Nie, Min Zhong, Yangguang Gao, Fei Ding, Hang Li, Yongmin Zhang & Xianran He. (2015) Synthesis and potential anticonvulsant activity of new 5,5-cyclopropanespirohydantoin derivatives. Medicinal Chemistry Research 24:12, pages 4207-4216.
Crossref
Crossref
Meir Bialer & Christian Elger. 2015. The Treatment of Epilepsy. The Treatment of Epilepsy
447
459
.
Ayman El-Faham, Muhammad Farooq, Sherine Khattab, Nael Abutaha, Mohammad Wadaan, Hazem Ghabbour & Hoong-Kun Fun. (2015) Synthesis, Characterization, and Anti-Cancer Activity of Some New N′-(2-Oxoindolin-3-ylidene)-2-propylpentane hydrazide-hydrazones Derivatives. Molecules 20:8, pages 14638-14655.
Crossref
Crossref
Tawfeeq Shekh-Ahmad, Hafiz Mawasi, John H. McDonough, Boris Yagen & Meir Bialer. (2015) The potential of sec -butylpropylacetamide (SPD) and valnoctamide and their individual stereoisomers in status epilepticus. Epilepsy & Behavior 49, pages 298-302.
Crossref
Crossref
Tawfeeq Shekh-Ahmad, Hafiz Mawasi, John H. McDonough, Richard H. Finnell, Bogdan J. Wlodarczyk, Eylon Yavin & Meir Bialer. (2014) Enantioselective pharmacodynamic and pharmacokinetic analysis of two chiral CNS-active carbamate derivatives of valproic acid. Epilepsia 55:12, pages 1944-1952.
Crossref
Crossref
Steve S Chung. (2014) Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate. Clinical Investigation 4:9, pages 839-846.
Crossref
Crossref
Christopher J.A. Cowie & Mark O. Cunningham. (2014) Peritumoral epilepsy: Relating form and function for surgical success. Epilepsy & Behavior 38, pages 53-61.
Crossref
Crossref
Doru Georg Margineanu. (2014) Systems biology, complexity, and the impact on antiepileptic drug discovery. Epilepsy & Behavior 38, pages 131-142.
Crossref
Crossref
Petra Malátková, Lucie Havlíková & Vladimír Wsól. (2014) The role of carbonyl reducing enzymes in oxcarbazepine in vitro metabolism in man. Chemico-Biological Interactions 220, pages 241-247.
Crossref
Crossref
Min Zhong, Yongmin Zhang & Xianran He. (2014) Synthesis and Anticonvulsant Activity of Ethyl 2,2-dimethyl-1-(2-substitutedhydrazinecarboxamido) Cyclopropanecarboxylate Derivatives. Chemical Biology & Drug Design 84:2, pages 234-241.
Crossref
Crossref
Mohammad Asif. (2014) Anticonvulsant potential of some traditional medicinal plants. TANG [HUMANITAS MEDICINE] 4:1, pages 1.1-1.13.
Crossref
Crossref
Alberto Verrotti, Giulia Loiacono, Alessandra Rossi & Gaetano Zaccara. (2014) Eslicarbazepine acetate: An update on efficacy and safety in epilepsy. Epilepsy Research 108:1, pages 1-10.
Crossref
Crossref
Steve S. Chung & Courtney Schusse. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions
133
169
.
Maria I. Morte, Bruno P. Carreira, Maria J. Falcão, António F. Ambrósio, Patrício Soares-da-Silva, Inês M. Araújo & Caetana M. Carvalho. (2013) Evaluation of neurotoxic and neuroprotective pathways affected by antiepileptic drugs in cultured hippocampal neurons. Toxicology in Vitro 27:8, pages 2193-2202.
Crossref
Crossref
Mohammad Asif. (2013) Anticonvulsant potential of some medicinal plants and their beneficial properties. TANG [HUMANITAS MEDICINE] 3:4, pages 27.1-27.13.
Crossref
Crossref
G. L. Viswanatha, C. G. Mohan, H. Shylaja, H. C. Yuvaraj & V. Sunil. (2013) Anticonvulsant activity of 1,2,3,4,6-penta-O-galloyl-β-d-glucopyranose isolated from leaves of Mangifera indica. Naunyn-Schmiedeberg's Archives of Pharmacology 386:7, pages 599-604.
Crossref
Crossref
Tomasz Plech, Jarogniew J. Luszczki, Monika Wujec, Jolanta Flieger & Magdalena Pizoń. (2013) Synthesis, characterization and preliminary anticonvulsant evaluation of some 4-alkyl-1,2,4-triazoles. European Journal of Medicinal Chemistry 60, pages 208-215.
Crossref
Crossref
Dongman Chao & Ying Xia. 2013. Current Research in Acupuncture. Current Research in Acupuncture
129
214
.
Meir Bialer. (2012) How did phenobarbital’s chemical structure affect the development of subsequent antiepileptic drugs (AEDs)?. Epilepsia 53:s8, pages 3-11.
Crossref
Crossref
Meir Bialer. (2012) Chemical properties of antiepileptic drugs (AEDs). Advanced Drug Delivery Reviews 64:10, pages 887-895.
Crossref
Crossref
Meir Bialer & Patricio Soares‐da‐Silva. (2012) Pharmacokinetics and drug interactions of eslicarbazepine acetate. Epilepsia 53:6, pages 935-946.
Crossref
Crossref
Naama Hen, Meir Bialer & Boris Yagen. (2012) Syntheses and Evaluation of Anticonvulsant Activity of Novel Branched Alkyl Carbamates. Journal of Medicinal Chemistry 55:6, pages 2835-2845.
Crossref
Crossref
Nieves C. Comelli, Pablo R. Duchowicz, Rosana M. Lobayan, Alicia H. Jubert & Eduardo A. Castro. (2012) QSPR Study of Valproic Acid and Its Functionalized Derivatives. Molecular Informatics 31:2, pages 181-188.
Crossref
Crossref
Leonardo Bonilha, Gabriel U. Martz, Steven S. Glazier & Jonathan C. Edwards. (2012) Subtypes of medial temporal lobe epilepsy: Influence on temporal lobectomy outcomes?. Epilepsia 53:1, pages 1-6.
Crossref
Crossref
Steve S. Chung, Kristen Kelly & Courtney Schusse. (2011) New and Emerging Treatments for Epilepsy: Review of Clinical Studies of Lacosamide, Eslicarbazepine Acetate, Ezogabine, Rufinamide, Perampanel, and Electrical Stimulation Therapy. Journal of Epilepsy Research 1:2, pages 35-46.
Crossref
Crossref
Elżbieta Pękala, Anna M. Waszkielewicz, Edward Szneler, Maria Walczak & Henryk Marona. (2011) Synthesis and anticonvulsant activity of trans- and cis-2-(2,6-dimethylphenoxy)-N-(2- or 4-hydroxycyclohexyl)acetamides and their amine analogs. Bioorganic & Medicinal Chemistry 19:22, pages 6927-6934.
Crossref
Crossref
Bei Liu, Tao Wang, Liang Wang, Chao Wang, Hua Zhang & Guo-Dong Gao. (2011) Up-regulation of major vault protein in the frontal cortex of patients with intractable frontal lobe epilepsy. Journal of the Neurological Sciences 308:1-2, pages 88-93.
Crossref
Crossref
E. Perucca, C. Elger, P. Halász, A. Falcão, L. Almeida & P. Soares-da-Silva. (2011) Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures. Epilepsy Research 96:1-2, pages 132-139.
Crossref
Crossref
Xiao-ling DUAN & Nong XIAO. (2011) From levetiracetam to brivaracetam: development of antiepileptic drugs. Academic Journal of Second Military Medical University 31:5, pages 550-553.
Crossref
Crossref
Hans-Georg Häcker, Manuela Meusel, Melanie Aschfalk & Michael Gütschow. (2010)
Solid-Phase Synthesis of Disubstituted
N
-Acylureas from Resin-Bound Ureas and Acyl Chlorides
. ACS Combinatorial Science 13:1, pages 59-64.
Crossref
Crossref
Simon Shorvon. 2010. Handbook of Epilepsy Treatment. Handbook of Epilepsy Treatment
378
407
.
Gabriel Rubio, Francisco López-Muñoz, Francisco Ferre, Isabel Martínez-Gras, Guillermo Ponce, José M. Pascual, Miguel A. Jiménez-Arriero & Cecilio Alamo. (2010) Effects of Zonisamide in the Treatment of Alcohol Dependence. Clinical Neuropharmacology 33:5, pages 250-253.
Crossref
Crossref
J. Ruiz-Giménez, J.C. Sánchez-Álvarez, F. Cañadillas-Hidalgo & P.J. Serrano-Castro. (2010) Antiepileptic treatment in patients with epilepsy and other comorbidities. Seizure 19:7, pages 375-382.
Crossref
Crossref
Gilberto Alves, Ana Fortuna, Joana Sousa, Rosa Direito, Anabela Almeida, Marília Rocha, Amílcar Falcão & Patrício Soares-da-Silva. (2010) Enantioselective Assay for Therapeutic Drug Monitoring of Eslicarbazepine Acetate: No Interference With Carbamazepine and Its Metabolites. Therapeutic Drug Monitoring 32:4, pages 512-516.
Crossref
Crossref
Ana Fortuna, Gilberto Alves, Amílcar Falcão & Patrício Soares‐da‐Silva. (2010) Binding of licarbazepine enantiomers to mouse and human plasma proteins. Biopharmaceutics & Drug Disposition 31:5-6, pages 362-366.
Crossref
Crossref
Mark P. Grillo. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
26
.
Michael R. Sperling, Andrew Greenspan, Joyce A. Cramer, Patrick Kwan, Reetta Kälviäinen, Jonathan J. Halford, Jennifer Schmitt, Eric Yuen, Thomas Cook, Magali Haas & Gerald Novak. (2010) Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo‐controlled trials. Epilepsia 51:3, pages 333-343.
Crossref
Crossref
Jakob A. Shimshoni, Boris Yagen, Bogdan Wlodarczyk, Richard H. Finnell, Volker Schurig & Meir Bialer. (2010) Evaluation of stereoselective anticonvulsant, teratogenic, and pharmacokinetic profile of valnoctylurea (capuride): A chiral stereoisomer of valproic acid urea derivative. Epilepsia 51:3, pages 323-332.
Crossref
Crossref
Christian E. Elger, Hermann Stefan, Allison Mann, Milind Narurkar, Yijun Sun & Carlos Perdomo. (2010) A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures. Epilepsy Research 88:2-3, pages 255-263.
Crossref
Crossref
Meir Bialer & H. Steve White. (2010) Key factors in the discovery and development of new antiepileptic drugs. Nature Reviews Drug Discovery 9:1, pages 68-82.
Crossref
Crossref
Cecilie Johannessen Landmark & Svein I. Johannessen. 2010. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Brain Protection in Schizophrenia, Mood and Cognitive Disorders
485
504
.
Curtis W. Dewey, Sofia Cerda-Gonzalez, Jonathan M. Levine, Britton L. Badgley, Julie M. Ducoté, Gena M. Silver, Jocelyn J. Cooper, Rebecca A. Packer & James A. Lavely. (2009) Pregabalin as an adjunct to phenobarbital, potassium bromide, or a combination of phenobarbital and potassium bromide for treatment of dogs with suspected idiopathic epilepsy. Journal of the American Veterinary Medical Association 235:12, pages 1442-1449.
Crossref
Crossref
Florent F. Richy, Soutrik Banerjee, Yves Brabant & Sandra Helmers. (2009) Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: An indirect comparison of treatment-emergent adverse events using meta-analytic techniques. Epilepsy & Behavior 16:2, pages 240-245.
Crossref
Crossref
Helena Gauffin, Lena Raty & Birgitta Söderfeldt. (2009) Medical outcome in epilepsy patients of young adulthood—A 5-year follow-up study. Seizure 18:4, pages 293-297.
Crossref
Crossref
Neta Pessah, Meir Bialer, Bogdan Wlodarczyk, Richard H. Finnell & Boris Yagen. (2009) α-Fluoro-2,2,3,3-Tetramethylcyclopropanecarboxamide, a Novel Potent Anticonvulsant Derivative of a Cyclic Analogue of Valproic Acid. Journal of Medicinal Chemistry 52:8, pages 2233-2242.
Crossref
Crossref
Jarogniew J. Łuszczki. (2009) Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions. Pharmacological Reports 61:2, pages 197-216.
Crossref
Crossref
Mark P. Grillo. 2009. Drug Metabolism Handbook. Drug Metabolism Handbook
629
653
.
Meir Bialer, Svein I. Johannessen, René H. Levy, Emilio Perucca, Torbjörn Tomson & H. Steve White. (2009) Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (EILAT IX). Epilepsy Research 83:1, pages 1-43.
Crossref
Crossref
Gilberto Alves, Isabel Figueiredo, Margarida Castel-Branco, Nulita Lourenço, Amílcar Falcão, Margarida Caramona & Patrício Soares-da-Silva. (2008) Disposition of eslicarbazepine acetate in the mouse after oral administration. Fundamental & Clinical Pharmacology 22:5, pages 529-536.
Crossref
Crossref
Akinobu Okada, Yuko Onishi, Boris Yagen, Jakob Avi Shimshoni, Dan Kaufmann, Meir Bialer & Michio Fujiwara. (2008) Tetramethylcyclopropyl analogue of the leading antiepileptic drug, valproic acid: Evaluation of the teratogenic effects of its amide derivatives in NMRI mice. Birth Defects Research Part A: Clinical and Molecular Teratology 82:9, pages 610-621.
Crossref
Crossref
Luis Almeida, Ioana Minciu, Teresa Nunes, Nicolina Butoianu, Amilcar Falcão, Sandra-Adriana Magureanu & Patrício Soares-da-Silva. (2008) Pharmacokinetics, Efficacy, and Tolerability of Eslicarbazepine Acetate in Children and Adolescents With Epilepsy. The Journal of Clinical Pharmacology 48:8, pages 966-977.
Crossref
Crossref
Gilberto Alves, Isabel Figueiredo, Amílcar Falcão, Margarida Castel‐Branco, Margarida Caramona & Patrício Soares‐DA‐Silva. (2008)
Stereoselective disposition of
S
‐ and
R
‐licarbazepine in mice
. Chirality 20:6, pages 796-804.
Crossref
Crossref
Juan Antonio Armijo Simón. (2008) Avances en el tratamiento médico de la epilepsia. Medicina Clínica 130:6, pages 216-218.
Crossref
Crossref
Carlos Fontes-Ribeiro, Tice Macedo, Teresa Nunes, Carla Neta, Teófilo Vasconcelos, Rui Cerdeira, Ricardo Lima, José-Francisco Rocha, Amílcar Falcão, Luís Almeida & Patrício Soares-da-Silva. (2008) Dosage Form Proportionality and Food Effect of the Final Tablet Formulation of Eslicarbazepine Acetate. Drugs in R & D 9:6, pages 447-454.
Crossref
Crossref
Cecilie Johannessen Landmark. (2008) Antiepileptic Drugs in Non-Epilepsy Disorders. CNS Drugs 22:1, pages 27-47.
Crossref
Crossref
Cecilie Johannessen Landmark & Svein I Johannessen. (2008) Pharmacological Management of Epilepsy. Drugs 68:14, pages 1925-1939.
Crossref
Crossref
Cecilie Johannessen LandmarkSvein I. Johannessen. (2008) Modifications of Antiepileptic Drugs for Improved Tolerability and Efficacy. Perspectives in Medicinal Chemistry 2, pages 1177391X0800200.
Crossref
Crossref
Gilberto Alves, Isabel Figueiredo, Margarida Castel‐Branco, Ana Loureiro, Ana Fortuna, Amílcar Falcão & Margarida Caramona. (2007) Enantioselective HPLC‐UV method for determination of eslicarbazepine acetate (BIA 2‐093) and its metabolites in human plasma. Biomedical Chromatography 21:11, pages 1127-1134.
Crossref
Crossref
Emilio Perucca, Jacqueline French & Meir Bialer. (2007) Development of new antiepileptic drugs: challenges, incentives, and recent advances. The Lancet Neurology 6:9, pages 793-804.
Crossref
Crossref
Gerd Dannhardt & Werner Kiefer. (2007) Neue Antiepileptika in der Entwicklung. Substanzen mit neuen Wirkmechanismen. Pharmazie in unserer Zeit 36:4, pages 306-310.
Crossref
Crossref
Gerd Dannhardt & Werner Kiefer. (2007) Antiepileptika – Wirkprinzipien und strukturelle Parameter. Wissenswertes zur Pharmakokinetik und Pharmakodynamik. Pharmazie in unserer Zeit 36:4, pages 270-281.
Crossref
Crossref
J. A. Shimshoni, E. C. Dalton, A. Jenkins, S. Eyal, K. Ewan, R. S. B. Williams, N. Pessah, B. Yagen, A. J. Harwood & M. Bialer. (2007) The Effects of Central Nervous System-Active Valproic Acid Constitutional Isomers, Cyclopropyl Analogs, and Amide Derivatives on Neuronal Growth Cone Behavior. Molecular Pharmacology 71:3, pages 884-892.
Crossref
Crossref
Ulrich Klotz. (2007) The Role of Pharmacogenetics in the Metabolism of Antiepileptic Drugs. Clinical Pharmacokinetics 46:4, pages 271-279.
Crossref
Crossref
Meir Bialer & Boris Yagen. (2007) Valproic acid: Second generation. Neurotherapeutics 4:1, pages 130-137.
Crossref
Crossref
Steven C. Schachter. (2007) Currently available antiepileptic drugs. Neurotherapeutics 4:1, pages 4-11.
Crossref
Crossref
Luis Almeida & Patrício Soares-da-Silva. (2007) Eslicarbazepine acetate (BIA 2-093). Neurotherapeutics 4:1, pages 88-96.
Crossref
Crossref
Meir Bialer, Svein I. Johannessen, Harvey J. Kupferberg, René H. Levy, Emilio Perucca & Torbjörn Tomson. (2007) Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII). Epilepsy Research 73:1, pages 1-52.
Crossref
Crossref